|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Advanced Viral Research Corp., of Yonkers, N.Y., completed a $3 million institutional financing, funds the firm says enable Israeli clinical studies of Product R to move forward. Advanced Viral issued and sold 21.5 million shares of common stock. Advanced Viral also issued warrants to purchase an aggregate of about 16 million shares of common stock, exercisable for five years from the date of issuance at 25 cents apiece. H.C. Wainwright and Co., of Boston, served as placement agent.
Altair Nanotechnologies Inc., of Reno, Nev., named its new pharmaceutical for the removal of phosphate ions in kidney dialysis patients Renazorb. Developed to treat elevated phosphate ...